- Report
- May 2026
- 153 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 130 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 138 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 349 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 350 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 219 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 168 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 190 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 351 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 224 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 137 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 208 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 226 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 368 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 253 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 260 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 271 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- January 2026
- 186 Pages
Global
From €4007EUR$4,500USD£3,494GBP
- Report
- January 2026
- 180 Pages
Global
From €3157EUR$3,545USD£2,753GBP
€3508EUR$3,939USD£3,059GBP
- Report
- January 2026
- 187 Pages
Global
From €3157EUR$3,545USD£2,753GBP
€3508EUR$3,939USD£3,059GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more